Navigation Links
Childhood cancer research in danger
Date:2/8/2011

At a time when the effects of paediatric oncology research have meant that more and more children survive cancer, its funding is too low and dependent on short-term grants to be able to sustain this improvement in the long-term, says a report supported by the EU-funded 7th Framework Programme project Eurocancercoms and published on-line in ecancer today*. The authors also looked at the citation impact of paediatric oncology papers and found that childhood cancer research is once again the poor relation; unlike cancer papers in general, paediatric oncology papers received fewer citations than the average for the journals in which they were published.

"Working in this kind of discouraging environment makes the achievements of childhood cancer research all the more praiseworthy", said Professor Richard Sullivan, from the Centre for Global OncoPolicy, London, UK, and one of the authors of the report. "About 80% of all childhood cancer patients now survive, due to massive improvements in diagnosis and treatment over the last forty years."

'The State of Research into Children with Cancer across Europe New Policies for a New Decade' is published by the European Society for Paediatric Oncology (SIOPE) and the Centre for Global OncoPolicy. The report will be presented today ( Wednesday 9 February) at a special event in the European Parliament to mark International Childhood Cancer Awareness Day to a wide range of EU policymakers as well as young cancer patients and parents. The authors set out to look at the current state of paediatric oncology research in Europe.

They found that countries with a larger oncology burden, such as those in Eastern Europe, tended not to collaborate in research with those with a better-developed research structure, and this in turn affected the care they were able to give young patients. "Paediatric oncologists from ten countries were asked about their national situations and the differences were striking", said Professor Kathy Pritchard-Jones, Cancer Programme Director at the UCL Institute of Child Health, London, UK and Past President of SIOPE. "For example, a respondent from Bosnia-Herzegovina cited lack of hospital space, no specialist paediatric oncology radiologists, and inadequate diagnostic facilities, with everything adapted to adult patients. The Czech Republic said that research grants were usually for only three years and there was little support for young scientists to attend international courses and congresses which could help harmonise the level of knowledge across European states."

In Italy, it was the fragmentation of childhood cancer care which concerned doctors, with nearly 50 centres specialising in paediatric haematology and oncology, and a lack of co-ordination between research laboratories and clinics. In comparison, Sweden has only six paediatric oncology units, which work closely together but, even there, there are problems of funding and a lack of experienced staff. The UK expressed concern about the effects of health service cuts on children's cancer care, and the fact that infrastructure changes had moved paediatrics alongside the adult cancer model, meaning that research for children now has to compete for funds at a much more visible level with research for adults.

The authors also found large differences in the provision of information on childhood cancer, with variations in the involvement of parental organisations, the use of digital media, and the adoption of a common national standard for information provision. "When a child is sick, the provision of accurate information to the patient and family is essential" said Professor Sullivan. "We believe that the establishment of a European Common Information Portal could do much to tackle major deficiencies in information in countries with few or no patient organisations, or where the existence of a large number of languages make access to such information difficult."

The authors call for adequate long-term EU funding to support a Europe-wide clinical trials network for paediatric oncology. "This is an essential prerequisite for the effective testing and dissemination of new therapies and techniques", said Professor Pritchard-Jones. "We also need to study treatment outcomes, and for this the creation of a European Childhood Cancer Epidemiological Registry is essential. With these tools we can maintain the enormous progress that has been made in the past. Without them, we run the risk of jeopardising that progress and failing children who are dependent on us for their survival."


'/>"/>

Contact: Mary Rice
mary@mrcommunication.org
ECCO-the European CanCer Organisation
Source:Eurekalert

Related medicine news :

1. Protein may be key to new treatment in a childhood cancer
2. PanCareSurFup: Major EU project to tackle complications of childhood cancer treatment
3. Childhood obesity linked to health habits, not heredity: U-M study
4. Breast-Feeding May Counter Some Effects of Childhood Cancer
5. Grant to prevent young childhood obesity
6. Childhood Last Name Predicts Whether You Buy Early, Late: Study
7. Enhanced early childhood education pays long-term dividends in better health
8. Majority of U.S. Adults Had Troubled Childhoods: CDC
9. Gene Research Brings Insight Into Deadly Childhood Brain Tumor
10. CHOP experts collaborate in gene survey of childhood brain cancer; intriguing clues found
11. Decades after childhood radiation, thyroid cancer a concern
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
(Date:4/28/2017)... ... 28, 2017 , ... Bill Howe started his sewer and drain company in ... Howe joined the team, the Bill Howe brand was born and they began cultivating ... giving back to the San Diego community in which they worked, lived and were ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a leading ... Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, a ... of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and Vitamin ...
(Date:4/27/2017)... ... April 27, 2017 , ... Today, Jefferson Health in Philadelphia ... announced an agreement to create the Jane and Leonard Korman Respiratory Institute in ... Leonard Korman Family Foundation. The collaboration leverages the strengths of each organization and ...
(Date:4/27/2017)... ... 27, 2017 , ... Last night, Christine Collins of New ... for her extraordinary compassion and lifelong dedication to serve others. Since 1997, Home ... the prestigious award each year – identifying a CAREGiver who has exemplified exceptional ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical device ... markets with innovative and proprietary products, will release financial ... after the market close on Tuesday, May 2, 2017. ... call and webcast to discuss its financial results the ... p.m. Eastern Time (3:30 p.m. Central Time). Darin ...
(Date:4/18/2017)... -- Research and Markets has announced the addition of ... offering. ... market to grow at a CAGR of 6.35% during the period ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
Breaking Medicine Technology: